Podcast Building an AI-first company: What these two business leaders learned from top experts This week on the GeekWire Podcast, our guests are Adam Brotman and Andy Sack, co-authors of AI First: The Playbook… Read More
Biotech giant Moderna will open tech office in Seattle, plans to hire up to 220 workers Cambridge, Mass.-based biotech company Moderna is opening an office in Seattle to build up its tech capacity, the company announced… Read More
FDA says Moderna’s COVID-19 vaccine, which began its trials in Seattle, is ‘highly effective’ Another COVID-19 vaccine is on the verge of authorization after an FDA analysis determined Moderna’s vaccine as safe and “highly… Read More
‘As good as it gets’: Moderna’s COVID-19 vaccine, which got its start in Seattle, is 94.5% effective https://www.youtube.com/watch?v=qJlP91xjvsQ Biotech giant Moderna on Monday announced that its COVID-19 vaccine was 94.5% effective in preventing the disease during Phase… Read More
Pfizer’s promising COVID-19 vaccine is good news for Moderna’s trials, Fauci says Pharmaceutical giant Pfizer on Monday announced promising results from its COVID-19 vaccine trials, showing that it was more than 90%… Read More
What gives you hope? Inspiration from scientists, entrepreneurs and innovators as anxious public awaits historic election results Well, here we are: rattled, unsettled and full of anxiety. Less than 24 hours before a historic U.S. election, we… Read More
Experts foresee triumphs and tragedies in worldwide quest for COVID-19 vaccine The good news is that Operation Warp Speed, the multibillion-dollar effort to develop vaccines for COVID-19, is moving ahead at… Read More
Positive news about Seattle-tested coronavirus vaccine sends stock market sharply higher Massachusetts-based Moderna’s share price — and the stock market as a whole — were lifted today by the company’s encouraging… Read More
After good results in Seattle, COVID-19 vaccine will face key trials this summer, Moderna CEO says The coronavirus vaccine trial that started out in Seattle is progressing well enough to get onto Food and Drug Administration’s… Read More
